AOD-9604

AOD-9604 is a modified fragment of human growth hormone (hGH 176-191) designed to stimulate fat burning without increasing growth hormone or IGF-1 levels. It specifically targets metabolic pathways involved in fat breakdown and fat formation, making it effective for reducing stubborn and visceral fat.

• Overweight or obesity (BMI above 25) • Visceral and abdominal fat reduction • Metabolic slowdown associated with aging • Enhancing fat loss while maintaining muscle mass • Suitable for patients who cannot tolerate stimulant-based weight loss medications • Can be used alongside GLP-1 medications but does not replace them

• Increases fat breakdown through lipolysis activation • Reduces new fat formation • Targets stubborn adipose tissue • Does not affect blood sugar or IGF-1 levels • Safe metabolic profile suitable for long-term use • Supports gradual and steady fat loss

Standard Dosing

• 500 mcg subcutaneously once daily • Administer in the morning while fasting or before bed • Avoid injecting within 2 hours of meals, especially carbohydrate-heavy meals

Inject on an empty stomach (avoid food for 2 hours before and 30 to 45 minutes after). • Morning fasting or bedtime dosing provides the best metabolic response. • Route: Subcutaneous (SQ) — abdomen preferred. • Rotate injection sites to prevent irritation

• Local injection site irritation (improves with rotation) • Mild headache • Slight increase in hunger • Temporary fatigue